ArticleJournal of managed care & specialty pharmacy2021

Budget impact analysis of darolutamide for treatment of nonmetastatic castration-resistant prostate cancer.

Sreevalsa Appukkuttan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.